Pneumocystis pneumonia among HIV patients in Malaysia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 6, 2009, Pages 1293-1297

  Siti Asma, H ^c   Mustafa, Mahiran ^d   Abdullah, Shukri ^a   Zaidah, A R ^c   Nurhaslindawati, A R ^c   Sarimah, A ^b   Chan, Y Y ^c   Ravichandran, M ^c  

^a Department of Anatomy ^*

^b School of Medical Sciences

^c SCHOOL OF HEALTH SCIENCES   (Malaysia)

^d Hospital Raja Perempuan Zainab II   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76749153837     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Barry SM, Johnson MA. Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management. HIV Med 2001; 2: 123-132 (Pubitemid 33114751)
2. Centers for Disease Control (CDC). Guidelines for HAART in AIDS patients. 2006. [Cited 2009 Sep 6]. Available from: URL: www.cdc.gov/eid
3. Curtis JR, Paauw DS, Wenrich MD, Carline JD, Ramsey PG. Ability of primary care physicians to diagnose and manage Pneumocystis carinii pneumonia. J Gen Intern Med 1995; 10: 395-399
4. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447-454
5. Foudraine NA, Hovenkamp E, Notermans DW, et al. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 1999; 13: 177-184 (Pubitemid 29050405)
6. Hanvanich M, Ruxrungtham K, Charoensiri V, Pasurapunya W, Srivichayakul S, Phanuphak P. Opportunistic infections among AIDS patients at Chulalongkhorn University Hospital. Bangkok: International Symposium on Biomedical Research Issue of HIV Infected in Thailand, 2001.
7. Kirk O, Gatell JM, Mocroft A, et al. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. Euro SIDA Study Group JD. Am J Respir Crit Care Med 2000; 162: 865-872
8. Kunimoto DY, Chui L, Nobert E, Houston S. Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy. Int J Tuberc Lung Dis 1999; 3: 944-947
9. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000; 69: 376-380 (Pubitemid 30636242)
10. Ministry of Health Malasia. Annual report, AIDS/ STD section, Kuala Lumpur: Ministry of Health, 2004.
11. Ruffini D, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 2002; 16: 105-112 (Pubitemid 34062187)
12. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8: 891-896
13. Wakefield AE. Pneumocystis carinii. Br Med Bull 2002; 61:175-188
14. Wolff AJ, O'Donnell AE. Pulmonary manifestation of HIV infection in the era of highly active antiretroviral therapy. Chest 2001; 120: 1888-1893 (Pubitemid 34053450)